Quick Answer
ClearPoint Neuro, Inc. reported Stockholders Equity of $28.02 million for the year ending 2025.
- ClearPoint Neuro, Inc. showed an increase of +10.4% in Stockholders Equity from 2024 to 2025.
- This data is from ClearPoint Neuro, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: -$3.63 million | Q2 2015: -$5.88 million | Q3 2015: -$5.82 million | Q1 2016: -$3.61 million | Q2 2016: -$3.96 million | Q3 2016: $574.6 thousand | Q1 2017: -$2.20 million | Q2 2017: $8.53 million | Q3 2017: $7.28 million | Q1 2018: $4.75 million | Q2 2018: $3.56 million | Q3 2018: $2.49 million | Q1 2019: $442.6 thousand | Q2 2019: $6.91 million | Q3 2019: $6.01 million | Q1 2020: $2.76 million | Q2 2020: $1.34 million | Q3 2020: $149.0 thousand | Q1 2021: $43.98 million | Q2 2021: $47.97 million | Q3 2021: $44.12 million | Q1 2022: $45.73 million | Q2 2022: $42.82 million | Q3 2022: $39.88 million | Q1 2023: $32.58 million | Q2 2023: $27.41 million | Q3 2023: $24.09 million | Q1 2024: $34.58 million | Q2 2024: $32.13 million | Q3 2024: $29.00 million | Q1 2025: $19.99 million | Q2 2025: $19.74 million | Q3 2025: $15.87 million.
- Over the full 17 years of available data (2009 to 2025), ClearPoint Neuro, Inc.'s Stockholders Equity has grown by 383.4%.
- Historical annual values: Fiscal year 2025: $28.02 million | Fiscal year 2024: $25.39 million | Fiscal year 2023: $21.17 million | Fiscal year 2022: $36.89 million | Fiscal year 2021: $48.79 million | Fiscal year 2020: $2.38 million | Fiscal year 2019: $4.59 million | Fiscal year 2018: $1.51 million | Fiscal year 2017: $5.83 million | Fiscal year 2016: -$756.1 thousand | Fiscal year 2015: -$1.98 million | Fiscal year 2014: -$100.3 thousand | Fiscal year 2013: -$6.83 million | Fiscal year 2012: -$7.87 million | Fiscal year 2011: -$21.84 million | Fiscal year 2010: -$15.34 million | Fiscal year 2009: -$9.89 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: